BRIEF-Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation

Reuters
Oct 17
BRIEF-<a href="https://laohu8.com/S/ACHV">Achieve Life</a> Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation

Oct 17 (Reuters) - Achieve Life Sciences Inc ACHV.O:

  • ACHIEVE LIFE SCIENCES RECEIVES FDA COMMISSIONER'S NATIONAL PRIORITY VOUCHER FOR CYTISINICLINE FOR TREATMENT OF NICOTINE DEPENDENCE FOR E-CIGARETTE OR VAPING CESSATION

  • ACHIEVE LIFE SCIENCES INC - FDA-ASSESSMENT TIME REDUCED TO 1-2 MONTHS FOR CYTISINICLINE

Source text: ID:nGNX4nHRGh

Further company coverage: ACHV.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10